lilly retatrutide trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Eli Lilly's Next-Gen Obesity Drug

All services provided by Huemn are intended solely to promote overall wellness, and information on this site is published for educational purposes

Wegovy is an injectable medication containing semaglutide, a GLP-1 receptor agonist

Decisions should be individualized based on weight goals, health conditions, and the risk of weight regain

(2024) Compare and contrast the glucagon-like peptide-1 receptor agonists FDA (2023) Prescribing Information, Saxenda FDA (2023) Prescribing Information, Ozempic Novo Nordisk (2025) Ozempic Savings Offer Novo Nordisk (2025) Wegovy Supply Update Novo Nordisk (2025) Rybelsus Savings & Support Novo Nordisk (2025) Saxenda Savings Program Novo Nordisk (2025) Victoza Coverage & Reimbursement FAQs Novo Nordisk

Working with Tiffany has been fantastic